Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial (Q94586313)
Jump to navigation
Jump to search
scientific article published on 01 May 2020
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial |
scientific article published on 01 May 2020 |
Statements
Raltegravir versus efavirenz in antiretroviral-naive pregnant women living with HIV (NICHD P1081): an open-label, randomised, controlled, phase 4 trial (English)
Lisa M Frenkel
Blandina T Mmbaga
Esaú C João
R Leavitt Morrison
David E Shapiro
Nahida Chakhtoura
Maria Isabel S Gouvèa
Maria de Lourdes B Teixeira
Trevon L Fuller
James S Ngocho
Boniface N Njau
Ruth Mathiba
Zaynab Essack
Jose Henrique S Pilotto
Luis Felipe Moreira
Maria Jose Rolon
Pedro Cahn
Sinart Prommas
Timothy R Cressey
Kulkanya Chokephaibulkit
Peerawong Werarak
Lauren Laimon
Roslyn Hennessy
Patricia Anthony
Brookie M Best
George K Siberry